Condition: Neoplasm Metastases · Metastases, Neoplasm · Sponsor: Rutgers, The State University of New Jersey
The investigators hypothesize that with dose escalation to 40-50 Gy in ten fractions, the complete pain response rate at one month can be increased to 40-50% in painful non-spinal bone metastases. Additionally, the investigators hypothesize that utilizing a fractionation scheme with an escalated biologically equivalent dose (BED) will result in a higher proportion of participants responding to treatment, and will also lead to more durable responses. Furthermore, the investigators hypothesize that with dose escalation to 40-50 Gy in ten fractions, the complete pain response rate at one month can be increased to 35-45% in painful non-bone metastases
This description comes directly from the study's public registry record.
Matthew P Deek, MD · 732-253-3941 · Deekmp@cinj.Rutgers.edu
Salma Jabbour, MD · 732-253-3961 · jabbousk@cinj.rutgers.edu
Always discuss trial participation with your own doctor first.
| RWJBarnabas Health - Robert Wood Johnson University Hospital | Hamilton, New Jersey, United States | Not Yet Recruiting |
| RWJBarnabas Health - Monmouth Medical Center Southern Campus | Lakewood, New Jersey, United States | Recruiting |
| RWJBarnabas Health - Saint Barnabas Medical Center | Livingston, New Jersey, United States | Recruiting |
| Robert Wood Johnson University Hospital | New Brunswick, New Jersey, United States | Recruiting |
| Cancer Institute of New Jersey | New Brunswick, New Jersey, United States | Recruiting |
| RWJBarnabas Health - Robert Wood Johnson University Hospital | Somerset, New Jersey, United States | Recruiting |
| RWJBarnabas Health - Community Medical Center | Toms River, New Jersey, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05419518